Related Experiment Video
Updated: Aug 7, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Metabolic Profile of Patients with Long COVID: A Cross-Sectional Study
Daniel Carvalho de Menezes1, Patrícia Danielle Lima de Lima1, Igor Costa de Lima1
1Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil.
Insights
Long COVID patients often show metabolic imbalances, including high body mass index and abnormal blood markers. These metabolic issues correlate with more severe long COVID symptoms and previous hospitalizations.
Area of Science:
- Cardiology
- Metabolic Health
- Infectious Disease Epidemiology
Background:
- Post-acute sequelae of coronavirus disease 2019 (Long COVID) present with diverse symptoms.
- Metabolic parameter imbalances are increasingly recognized in Long COVID patients.
- Understanding clinical and laboratory markers is crucial for managing Long COVID.
Purpose of the Study:
- To identify clinical and laboratory markers associated with the disease course in Long COVID patients.
- To analyze metabolic, glycaemic, and inflammatory profiles in relation to Long COVID severity.
- To investigate the link between metabolic abnormalities and Long COVID outcomes in the Amazon region.
Main Methods:
- Cross-sectional analysis of 215 Long COVID patients from a clinical care program.
- Collection of clinical, sociodemographic, glycaemic, lipid, and inflammatory data.
- Comparison of marker prevalence between different Long COVID outcome groups.
Main Results:
- Abnormal metabolic profiles (high BMI, triglycerides, HbA1c, ferritin) were more common in severe Long COVID presentations.
- Previous hospitalization during acute COVID-19 was associated with worse Long COVID outcomes.
- Fatigue, dyspnoea, and muscle weakness were the predominant Long COVID symptoms.
Conclusions:
- Abnormal metabolic profiles are prevalent in patients with worse Long COVID.
- These findings suggest a link between Long COVID and cardiometabolic health disturbances.
- Further research into metabolic interventions for Long COVID is warranted.
Abstract:
A significant proportion of patients experience a wide range of symptoms following acute coronavirus disease 2019 (COVID-19). Laboratory analyses of long COVID have demonstrated imbalances in metabolic parameters, suggesting that it is one of the many outcomes induced by long COVID. Therefore, this study aimed to illustrate the clinical and laboratory markers related to the course of the disease in patients with long COVID. Participants were selected using a clinical care programme for long COVID in the Amazon region. Clinical and sociodemographic data and glycaemic, lipid, and inflammatory screening markers were collected, and cross-sectionally analysed between the long COVID-19 outcome groups. Of the 215 participants, most were female and not elderly, and 78 were hospitalised during the acute COVID-19 phase. The main long COVID symptoms reported were fatigue, dyspnoea, and muscle weakness. Our main findings show that abnormal metabolic profiles (such as high body mass index measurement and high triglyceride, glycated haemoglobin A1c, and ferritin levels) are more prevalent in worse long COVID presentations (such as previous hospitalisation and more long-term symptoms). This prevalence may suggest a propensity for patients with long COVID to present abnormalities in the markers involved in cardiometabolic health.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Acute Coronary Syndrome III: Diagnostic Studies
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

